Morgan Stanley entities report 7.8% stake in American Well (AMWL)

Morgan Stanley units amend 13G/A, report 4.9% stake in Clough Global (GLQ)

BlackRock Duration Income Trust (NYSE: BLW) — Morgan Stanley reports 10.7% stake

Morgan Stanley units report ~9.3% stake in Calamos (CHW) — 5.9M shares

Morgan Stanley Smith Barney (WTTR) files to sell 90,000 Class A shares on NYSE

Morgan Stanley (LITE) broker files Form 144 reporting proposed sales of awards

Morgan Stanley Smith Barney to sell 3.14M AUPH shares (AUPH) on 05/11/2026

Broker (MS Smith Barney) files Form 144 to sell 1,000 RGLD shares (RGLD)

Morgan Stanley and Parametric (BOE) disclose shared 6.1% holdings

Morgan Stanley files Amendment to Schedule 13G/A for Affirm (NASDAQ: AFRM), 7.1% stake

RNG Maintained by Morgan Stanley -- Price Target Raised to $40

Morgan Stanley files amendment; holds 2.7% of Core & Main (NYSE: CNM)

NICE Maintained by Morgan Stanley -- Price Target Lowered to $13

OLN Maintained by Morgan Stanley -- Price Target Raised to $22.0

Morgan Stanley gatekeepers drop BlackRock from 2 Pathway funds

CC Maintained by Morgan Stanley -- Price Target Raised to $21

RCUS Maintained by Morgan Stanley -- Price Target Raised to $22

Morgan Stanley & Parametric (FTF) report 7.5% stake in Franklin LTD Duration Trust

Morgan Stanley reporting units hold 8.0% of CervoMed (CRVO) in Schedule 13G/A

Morgan Stanley, Atlanta Capital amend 13G/A for CACI (CACI) holdings